Viemed Healthcare Inc Stock Price, News & Analysis

Viemed Healthcare has announced its upcoming Quarterly Conference Call scheduled for May 9, 2023, at 11:00 a.m. ET. Participants can join the call by dialing 877-407-6176 for US callers or +1 201-689-8451 for international participants. Financial professionals interested in asking questions must pre-register by emailing investorinfo@viemed.com by 12:00 p.m. ET on May 8, 2023. Additionally, a live audio webcast of the call will be available online. Following the event, a replay will be accessible in the Investor Relations section of the company’s website, www.viemed.com. Viemed is a leader in providing in-home medical equipment and respiratory healthcare services, leveraging technology to offer effective treatments.

Viemed Healthcare, Inc. (VMD) has announced its acquisition of Home Medical Products, Inc. (HMP) for approximately $31.75 million, expected to close in June 2023. HMP, a Tennessee-based provider of respiratory-focused home medical solutions, generated net revenues of around $28 million and an adjusted EBITDA of $6.8 million in 2022. The acquisition aims to enhance Viemed's growth strategy and expand its patient-centered care approach, with HMP's leadership team joining Viemed post-transaction. Funding will be sourced from cash reserves and undrawn credit facilities. This strategic move is designed to leverage synergies between the two companies, aiming for improved healthcare outcomes for patients.

Viemed Healthcare (NASDAQ: VMD) will present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 26, 2023, at 2:30 PM ET in Toronto, Ontario.

The conference aims to connect investors with insights from Canadian healthcare leaders. Viemed’s CEO Casey Hoyt and COO Todd Zehnder will discuss the company's operations and recent developments.

Registered attendees can schedule one-on-one meetings with management. A live webcast of the presentation will be available, with a replay accessible for 90 days post-event.

Viemed specializes in home medical equipment and post-acute respiratory healthcare services, delivering therapy through advanced technology. For more details, visit www.viemed.com.

Viemed Healthcare reported a record net revenue of $37.5 million for Q4 2022, marking a 30% increase year-over-year. Total net revenues for 2022 reached $138.8 million, including COVID-19 services. The company posted $2.4 million in net income for Q4 and $6.2 million for the year. Adjusted EBITDA stood at $9.3 million for Q4 and $30 million for the entire year. Despite a decline in cash balance to $16.9 million, Viemed remains debt-free, having repurchased 1.8 million shares at an average price of $5.33. Looking ahead, Viemed expects revenues of $38.0-$39.0 million for Q1 2023.